Eaton Vance Management’s Edwards Lifesciences EW Stock Holding History

Eaton Vance Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$74.9M	Buy	906,031 +3,287	+0.4%	+$272K	0.11%	189
2022 Q2	$85.8M	Buy	902,744 +425,326	+89%	+$40.4M	0.12%	176
2022 Q1	$56.2M	Buy	477,418 +131,712	+38%	+$15.5M	0.06%	289
2021 Q4	$44.8M	Buy	+345,706	New	+$44.8M	0.05%	321
2021 Q3	–	Sell	-396,484	Closed	-$41.1M	–	2214
2021 Q2	$41.1M	Buy	396,484 +32,045	+9%	+$3.32M	0.06%	317
2021 Q1	$30.5M	Buy	364,439 +33,615	+10%	+$2.81M	0.05%	353
2020 Q4	$30.2M	Sell	330,824 -54,649	-14%	-$4.99M	0.05%	345
2020 Q3	$30.8M	Buy	385,473 +21,615	+6%	+$1.73M	0.06%	289
2020 Q2	$25.1M	Buy	363,858 +195	+0.1%	+$13.5K	0.05%	300
2020 Q1	$22.9M	Buy	363,663 +52,494	+17%	+$3.3M	0.06%	280
2019 Q4	$24.2M	Sell	311,169 -91,716	-23%	-$7.13M	0.05%	302
2019 Q3	$29.5M	Buy	402,885 +819	+0.2%	+$60K	0.06%	249
2019 Q2	$24.8M	Buy	+402,066	New	+$24.8M	0.05%	272
2018 Q4	–	Sell	-417,885	Closed	-$24.3M	–	1186
2018 Q3	$24.3M	Sell	417,885 -53,193	-11%	-$3.09M	0.05%	258
2018 Q2	$22.9M	Sell	471,078 -72,609	-13%	-$3.52M	0.05%	261
2018 Q1	$25.3M	Sell	543,687 -79,302	-13%	-$3.69M	0.03%	350
2017 Q4	$23.4M	Sell	622,989 -51,807	-8%	-$1.95M	0.06%	258
2017 Q3	$24.6M	Sell	674,796 -222,648	-25%	-$8.11M	0.06%	239
2017 Q2	$35.4M	Sell	897,444 -735,558	-45%	-$29M	0.09%	196
2017 Q1	$51.2M	Buy	1,633,002 +719,583	+79%	+$22.6M	0.14%	155
2016 Q4	$28.5M	Buy	913,419 +167,718	+22%	+$5.24M	0.08%	197
2016 Q3	$30M	Buy	745,701 +112,371	+18%	+$4.52M	0.09%	183
2016 Q2	$21.1M	Buy	633,330 +533,952	+537%	+$17.8M	0.06%	213
2016 Q1	$2.92M	Hold	99,378	–	–	0.01%	483
2015 Q4	$2.62M	Hold	99,378	–	–	0.01%	506
2015 Q3	$2.36M	Buy	99,378 +66,378	+201%	+$1.57M	0.01%	520
2015 Q2	$783K	Hold	33,000	–	–	﹤0.01%	669
2015 Q1	$784K	Hold	33,000	–	–	﹤0.01%	722
2014 Q4	$701K	Hold	33,000	–	–	﹤0.01%	719
2014 Q3	$562K	Hold	33,000	–	–	﹤0.01%	735
2014 Q2	$473K	Buy	+33,000	New	+$473K	﹤0.01%	764